Thursday, October 06, 2022 11:43:21 AM
Or join by phone:
US: +1 253 215 8782 or +1 301 715 8592 or +1 309 205 3325 or +1 312 626 6799 or +1 346 248 7799 or +1 386 347 5053 or +1 564 217 2000 or +1 646 931 3860 or +1 669 444 9171 or +1 669 900 6833 or +1 719 359 4580 or +1 929 436 2866
Australia: +61 8 6119 3900 or +61 8 7150 1149 or +61 2 8015 6011 or +61 3 7018 2005 or +61 7 3185 3730
Webinar ID: 850 7847 7272
International numbers available: https://us06web.zoom.us/u/kbzsx6a7SV
The meeting ended but they sent the email with the instructions on how to join. You should be able to access the email from your phone and call from there. I will be posting the summary here after I finish up my errands for the day and re-listen to it. They did answer some questions I posted from here lol.
A lot of the information we already know since we know about the product/company/CEO but she did come out with new information. This is good for newcomers but overall it is looking extremely well as far as the future outlook goes.
US: +1 253 215 8782 or +1 301 715 8592 or +1 309 205 3325 or +1 312 626 6799 or +1 346 248 7799 or +1 386 347 5053 or +1 564 217 2000 or +1 646 931 3860 or +1 669 444 9171 or +1 669 900 6833 or +1 719 359 4580 or +1 929 436 2866
Australia: +61 8 6119 3900 or +61 8 7150 1149 or +61 2 8015 6011 or +61 3 7018 2005 or +61 7 3185 3730
Webinar ID: 850 7847 7272
International numbers available: https://us06web.zoom.us/u/kbzsx6a7SV
The meeting ended but they sent the email with the instructions on how to join. You should be able to access the email from your phone and call from there. I will be posting the summary here after I finish up my errands for the day and re-listen to it. They did answer some questions I posted from here lol.
A lot of the information we already know since we know about the product/company/CEO but she did come out with new information. This is good for newcomers but overall it is looking extremely well as far as the future outlook goes.
Recent BABYF News
- Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss • PR Newswire (US) • 05/15/2026 05:44:00 PM
- Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027 • PR Newswire (US) • 04/15/2026 11:30:00 AM
- Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards • PR Newswire (US) • 03/10/2026 11:00:00 AM
- Micro Cap Surges on Major Retail Breakthrough • AllPennyStocks.com • 05/27/2025 03:52:00 PM
